Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.

TMBMKGB-10Y | A complete U.K. 10 Year Gilt bond overview by MarketWatch. View the latest bond prices, bond market news and bond rates.

Forget the league table, it's all about the Premier League net spend table. And Chelsea, Man Utd, Tottenham and Arsenal are ahead of the other 16.